¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"rabbit hemorrhagic disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • pyramidal disease
    ÇǶó¹Ìµå½Å°æ·Îº´, Ãßü·Îº´
  • Paget¡¯s disease
    ÆÄÁ¦Æ®º´
  • parasitic disease
    1. ±â»ýÃæº´ 2. ±â»ýÃæÁúȯ
  • Parkinson¡¯s disease
    ÆÄŲ½¼º´
  • paroxysmal disease
    ¹ßÀÛ¼ºÁúȯ
  • pelvic inflammatory disease
    °ñ¹Ý¿°ÁõÁúȯ, °ñ¹Ý¿°
  • pericardial disease
    ½ÉÀ帷º´, ½É³¶Áúȯ
  • periodontal disease
    Ä¡ÁÖº´, Ä¡ÁÖÁúȯ
  • peripheral arterial disease
    ¸»Ãʵ¿¸ÆÁúȯ
  • peripheral vascular disease
    ¸»ÃÊÇ÷°üº´
  • Roussy-Levy disease
    ·ç½Ã-·¹ºñº´
  • runt disease
    ·±Æ®º´, ¼Ò¸ðº´
  • rat-bite disease
    Áã¹°¸²º´
  • Raynaud¡¯s disease
    ·¹À̳뺴
  • recessive hereditary disease
    ¿­¼ºÀ¯Àüº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • septic disease
    (¢¡sepsis) ÆÐÇ÷Áõ
  • sexually transmitted disease
    ¼ºº´, ¼º¸Å°³Áúȯ
  • sickle cell disease
    ³´ÀûÇ÷±¸º´, °â»óÀûÇ÷±¸º´
  • sleeping disease
    ¼ö¸éº´
  • slow disease
    Áö¹ßÁúȯ
  • specific disease
    ƯÀÌÁúȯ
  • spinal disease
    ô¼öº´
  • spinocerebellar disease
    ô¼ö¼Ò³úº´
  • spirochetal disease
    ½ºÇÇ·ÎÇ쟺´
  • sterility disease
    ºÒÀÓº´
  • storage disease
    ÃàÀûº´
  • subclinical disease
    ºÒÇö¼ºº´
  • systemic disease
    Àü½Åº´
  • thoracic disease
    °¡½¿º´, ÈäºÎÁúȯ
  • tick-borne disease
    Áøµå±â¸Å°³º´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • adult disease
    ¼ºÀκ´(à÷ìÑÜ»).
  • african sleeping disease
    ¾ÆÇÁ¸®Ä« ¼ö¸éº´(¡­â²ØùÜ»)
  • air borne disease
    °ø±â¸Å°³Áúȯ.
  • air pilots disease
    ºñÇàÁ¶Á¾»çº´.
  • air space disease
    °ø±â °ø°£ Áúȯ
  • aircraft disease
    Ç×°øº´.
  • allergic disease
    ¾Ë·¹¸£±â¼º Áúȯ, ¾Ë·¹¸£±âº´
  • allergic disease
    ¾Ë·¹¸£±â(¼º) Áúȯ
  • allergic respiratory disease
    ¾Ë·¹¸£±â¼º È£Èí±âº´
  • allergic skin disease
    ¾Ë·¹¸£±â(¼º)ÇǺΠÁúȯ
  • allergic skin disease
    ¾Ë·¹¸£±â[¼º] ÇǺκ´
  • alpha chain disease
    ¾ËÆÄ¼âº´(¡­áðÜ»).
  • alpha chain disease
    ¾ËÆÄ¼âÁúȯ
  • alpha-chain disease
    ¾ËÆÄ¼â Áúȯ(¡­áð òðü´)
  • alports syndrome(disease)
    ¾ËÆ÷Æ® ÁõÈıº(º´)(¡­ñøý¦ÏØ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • cystic disease of liver
    °£³¶¼ºÁúȯ(ÊÜÒ¥àõ òðü´).
  • cystic disease of liver
    ³¶¼º°£Áúȯ(³¶¼º°£Áúȯ).
  • cystic disease of lung
    È£Èí ³¶¼ºÆóÁúȯ(Ò¥àõøËòðü´).
  • cystic kidney disease
    ³¶¼º½ÅÁúȯ(Ò¥àõãìòðü´).
  • cystine disease
    ½Ã½ºÆ¾º´(¡­Ü»).
  • cystine storage disease
    ½Ã½ºÆ¾(ÃàÀû)º´ (¡­õëîÝÜ»).
  • cytomegalic inclusion disease
    ¼¼Æ÷ °Å´ë ºÀÀÔü º´
  • cytomegalic inclusion disease
    ¼¼Æ÷°Å´ëÈ­ ºÀÀÔüº´
  • cytomegalic inclusion disease =CID
    ¼¼Æ÷°Å´ë¼º ºÀÀÔüº´(¡­ËÝÓÞàõÜæìýô÷ Ü»), °Å´ë¼¼Æ÷ ºÀÀÔüÁúȯ(ËÝÓÞá¬øàÜæìýô÷òðü´).
  • cytomegalic inclusion disease =CID
    ¼¼Æ÷°Å´ë¼º ºÀÀÔüº´(¡­ËÝÓÞàõÜæìýô÷ Ü»), °Å´ë¼¼Æ÷ ºÀÀÔüÁúȯ(ËÝÓÞá¬øàÜæìýô÷òðü´).
  • cytomegalic inclusion disease =CID
    °Å´ë¼¼Æ÷ºÀÀÔüÁúȯ(ËÝÓÞá¬øàÜæìýô÷òðü´).
  • cytomegalic inclusion disease =cid
    °Å´ë¼¼Æ÷¼º ºÀÀÔüº´(¡­ËÝÓÞàõÜæìýô÷ Ü»), °Å´ë¼¼Æ÷ ºÀÀÔüÁúȯ(¡­òðü´)
  • degenerative brain disease
    ÅðÇ༺ ³úÁúȯ.
  • degenerative brain disease
    ÅðÇ༺ ³úÁúº´(÷Üú¼àõ ÒàòðÜ»).
  • degenerative disease
    ÅðÇ༺ Áúȯ.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
HSE herpes simplex encephalitis; hemorrhagic shock and encephalopathy
HSES hemorrhagic shock-encephalopathy syndrome
KHF Korean hemorrhagic fever
OHF Omsk hemorrhagic fever
SHF simian hemorrhagic fever
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
CESD Cholesterol ester storage disease
CLD Chronic Lung Disease
COAD Chronic Obstructive Airway Disease
COLD Chronic Obstructive Lung Disease
COPD Chronic Obstructive Lung Disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Urbach Wiethe disease
    ¿ì¹ÙÈåÀ§µ¥ º´
    À¯ÀüÀû ÁöÁú ´ë»ç ÀÌ»óÀ¸·Î, ÀÔ¼ú ³»¸é, Çô ¹Ø, ÀεÎ, ÈĵÎ, ±âŸ ¸¹Àº Àå¼Ò¿¡ À¯¸®Áú¾ç ÁöÁú-´çÁú È¥ÇÕ¹°ÀÇ È²»ö Ä§Âø¹°ÀÌ Æ¯Â¡ÀÌ´Ù. ¾ó±¼À̳ª »çÁö¿¡ °áÀý ±«¸¦ º¼ ¼ö ÀÖ´Ù. ±¤ °ú¹ÎÇüÀº Á¶Ç÷¼º ÇÁ·ÎÅäÆ÷¸£ÇǸ°ÁõÀÇ ÀÏÁ¾À̶ó°í »ý°¢µÈ´Ù.
  • vagabonds' disease
    ºÎ¶ûÀÚº´
  • valvular disease
    ÆÇ¸·º´, ÆÇ¸·º´
  • valvular disease of heart
    ½ÉÀåÆÇ¸·Áõ
  • valvular heart disease
    ÆÇ¸·¼º ½ÉÁúȯ
  • VDRL : Venereal Disease Research LaboratoryÀÇ ¾àÀÚ. ¸Åµ¶±ÕÀÇ Reagin¿¡ ´ëÇÑ Ç×ü·Î, ¸Åµ¶ÀÇ ¼±º°°Ë»ç·Î »ç¿ëµÇ¸ç ¸Åµ¶ Ä¡·á¿¡ ´ëÇÑ ¹ÝÀÀ ¿©ºÎ°¡ Ä¡·á È¿°ú ÆÇÁ¤¿¡ »ç¿ëµÈ´Ù. ¸Åµ¶ ¿Ü¿¡µµ Àü½Å¼º È«¹Ý¼º ³¶Ã¢(SLE), ·ù¸¶ÅäÀÌµå °üÀý¿° µî¿¡¼­µµ ¾ç¼ºÀ¸·Î ³ªÅ¸³¯ ¼ö ÀÖ´Ù.
    VDRL ¸é»ó ¹ÝÀÀ
  • venereal disease control
    ¼ºº´ °ü¸®
  • viral respiratory disease
    ¹ÙÀÌ·¯½º È£Èí±â Áúȯ, ¹ÙÀÌ·¯½º¼º È£Èí±â Áúȯ
  • virus disease
    ¹ÙÀÌ·¯½º Áúȯ
    1. ¹ÙÀÌ·¯½º´Â ¼÷ÁÖ¿¡ ħÀÔÇÏ°í ¶ÇÇÑ ¼÷ÁÖ¸¦ ÀÌ¿ëÇÏ¿© Áõ½ÄÇÔÀ¸·Î½á ÁúȯÀ» ÀÏÀ¸Å²´Ù. 2. È£Èí±â, ¼ÒÈ­±â°è, Ç¥ÇÇ-»óÇÇ, Ç츣Æä½º ¹ÙÀÌ·¯½º ÁúȯÀ¸·Î ³ª´­ ¼ö ÀÖ´Ù.
  • volkmann's disease
    ÆúÅ©¸¸ Áúȯ
    ¼±Ãµ¼º ¹ßÀÇ ±âÇüÀ¸·Î¼­ °æÁ·±Ù°ñÀÇ Å»±¸°¡ ¿øÀÎ.
  • Von Gierke's disease
    Æù ±â¿¡¸£ÄÉ º´
  • von Willebrand disease
    von Willebrand Áúȯ
  • von Willebrand's disease
    Æù ºô¸®ºê¶õÆ® º´, Æùºô·¹ºê¶õµåº´
    ¼±Ãµ¼º À¯Àü¼º ¼ÒÁú·Î, »ó¿°»öü¼º ¿ì¼º ÇüÁú·Î À¯ÀüµÇ¸ç ÃâÇ÷ ½Ã°£ÀÇ ¿¬Àå, ÀÀ°í ÀÎÀÚ 8ÀÇ °áÇÌÀ» Ư¡À¸·Î ÇÑ´Ù. ºñ ÃâÇ÷°ú °ü·ÃÀÌ ÀÖÀ¸¸ç ¿Ü»ó ȤÀº ¼ö¼ú ÈÄÀÇ ÃâÇ÷, ¿ù°æÃâÇ÷, ºÐ¸¸ ÈÄ ÃâÇ÷ µîÀÌ ÇöÀúÈ÷ Áõ°¡ÇÑ´Ù..
  • wasting disease
    ¼Ò¸ðº´
  • weber christian disease
    ¿þ¹ö-Å©¸®½ºÂùº´
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
Pellegrini's disease A calcific density in the medial collateral ligament and/or bony growth at the internal condyle of the femur.
Synonym: Pellegrini-Stieda disease.
(05 Mar 2000)
Pellegrini-Stieda disease A calcific density in the medial collateral ligament and/or bony growth at the internal condyle of the femur.
Synonym: Pellegrini-Stieda disease.
(05 Mar 2000)
glycogen storage disease <hepatology> A group of inherited metabolic disorders involving the enzymes responsible for the synthesis and degradation of glycogen. In some patients, prominent liver involvement is presented. In others, more generalised storage of glycogen occurs, sometimes with prominent cardiac involvement.
Synonym: glycogenosis
(12 Sep 2002)
glycogen storage disease type I <disease> An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycaemia due to lack of glucose production.
Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood.
Inheritance: autosomal recessive.
(12 Dec 1998)
glycogen storage disease type II <disease> Glycogenosis due to alpha-1,4-glucosidase (acid maltase) deficiency. It affects muscle, heart, and other organs.
(12 Dec 1998)
glycogen storage disease type III <disease> An autosomal recessive metabolic disorder due to deficient expression of amylo-1,6-glucosidase (one part of the glycogen debranching enzyme system).
The clinical course of the disease is similar to that of glycogen storage disease type I, but milder. Massive hepatomegaly, which is present in young children, diminishes and occasionally disappears with age. Levels of glycogen with short outer branches are elevated in muscle, liver, and erythrocytes. Six subgroups have been identified, with subgroups type IIIa and type IIIb being the most prevalent.
Inheritance: autosomal recessive
(12 Dec 1998)
glycogen storage disease type IV <disease> An autosomal recessive metabolic disorder due to a deficiency in expression of branching enzyme (alpha-1,4-glucan-6-alpha-glucosyltransferase), resulting in an accumulation of abnormal glycogen with long outer branches. Clinical features are muscle hypotonia and cirrhosis. Death from liver disease usually occurs before age 2.
Inheritance: autosomal recessive
(12 Dec 1998)
glycogen storage disease type V <disease> Glycogenosis due to muscle phosphorylase deficiency. Characterised by painful cramps following sustained exercise.
Inheritance: autosomal recessive
(12 Dec 1998)
glycogen storage disease type VI <disease> A hepatic glycogen storage disease in which there is an apparent deficiency of hepatic phosphorylase activity. However, studies have not been able to distinguish between phosphorylase deficiency and phosphorylase kinase deficiency in patients with hepatic glycogenosis.
(12 Dec 1998)
glycogen storage disease type VII <disease> An autosomal recessive muscle glycogen storage disease in which there is deficient expression of muscle phosphofructokinase activity, resulting in increased concentrations of glucose-6-phosphate and fructose-6-phosphate and low concentrations of fructose-1,6-diphosphate in muscle tissue.
Glycogen storage in muscle is increased, perhaps due to activation of glycogen synthase by accumulated glucose-6-phosphate. It has been proposed that shunting of glucose-6-phosphate and fructose-6-phosphate into the pentose phosphate pathway may result in increased synthesis of purines and pyrimidines, causing hyperuricaemia and gout.
Erythrocytes from patients may show decreased phosphofructokinase activity and 2,3-diphosphoglycerate deficiency. Exercise intolerance is present and severe congenital muscular dystrophy has been reported.
Inheritance: autosomal recessive
(12 Dec 1998)
glycogen storage disease type VIII <disease> An x-linked recessive hepatic glycogen storage disease resulting from lack of expression of phosphorylase-b-kinase activity. Symptoms are relatively mild; hepatomegaly, increased liver glycogen, and decreased leukocyte phosphorylase are present. Liver shrinkage occurs in response to glucagon.
Inheritance: X-linked recessive
(12 Dec 1998)
von Economo's disease A unique encephalitis, presumably viral in origin, which followed the influenza pandemic of 1914-1918. Symptoms included ophthalmoplegia and marked somnolence, and in many survivors, the delayed development of Parkinson's disease; the basis for postencephalitic Parkinsonism.
Synonym: encephalitis lethargica, polioencephalitis infectiva.
(05 Mar 2000)
Von Gierke's disease <disease> A congenital disease caused by a metabolic error in which the body deposits an abnormally high amount of glycogen in the kidneys and liver, the disease produces symptoms such as hypoglycaemia (low blood sugar) and hyperlipaemia (an excess of lipid molecules in the blood, which can lead to problems such as clogged arteries and heart attacks).
(09 Oct 1997)
von hippel-lindau disease <disease> A congenital disease characterised by the development of blood vesse ltumours in the retina of the eye and in the brain, lesions and cysts canalso develop in the spina lcord, pancreas, kidneys, and other organs.
(09 Oct 1997)
pelvic imflammatory disease <disease> The inflammation of any of the female pelvic organs, usually due to infection from a sexually transmitted disease. PID can result in sterility if left untreated.
(09 Oct 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á